YOU ARE HERE: LAT HomeCollectionsUrology


May 7, 1996 | From Times Staff and Wire Reports
Millions of men who suffer enlarged prostates now can choose a one-hour treatment over drugs or surgery: a machine that microwaves the prostate to relieve urinary symptoms. The Food and Drug Administration approved the Prostatron, which kills excess prostate tissue by heating the gland with microwaves, based on studies showing it may help 75% of patients. It is an outpatient procedure that appears to work better than drugs and clearly is safer than surgery, said Dr.
March 6, 1985 | United Press International
President Reagan will undergo his annual physical checkup Friday at the Bethesda Naval Hospital in suburban Maryland, the White House said today. He will be examined by a team of Navy doctors specializing in cardiovascular medicine, urology and ophthalmology, and they will reassess the condition that led to partial removal of a small benign polyp from the President's anal canal.
May 3, 1987
"Su Doctor," a free referral service designed to link Spanish-speaking patients with Spanish-speaking physicians, is being offered by Doctors Hospital of Santa Ana and Santa Ana Hospital Medical Center. By calling 1-800-44-DOCTOR weekdays and Saturdays, a caller can be referred to a Spanish-speaking doctor in areas of Orange County and Whittier.
January 6, 2000
Cryosurgery, which uses extremely cold temperatures to freeze and destroy cancerous cells, was 97% effective on men who had recurrences of prostate cancer, according to the results of a clinical study to be published today in the journal Urology. The study, sponsored by Endocare Inc. in Irvine, found that 42 of the 43 men in the clinical trial have been essentially disease-free since undergoing cryosurgery about two years ago. Cryosurgery has been used to treat first-time cancer patients.
August 19, 1996
Trimedyne Inc. said the U.S. Patent and Trademark Office upheld the validity of all of the claims on its laser patent. In 1995, Laser Industries Ltd. filed a petition with the patent office asking that Trimedyne's patent be reexamined. The patent gives Trimedyne the ability to manufacture other lasers with higher power and unique energy delivery capabilities, the company said.
July 18, 2012 | By Rosie Mestel, Los Angeles Times
Most patients diagnosed with early-stage prostate cancer will live just as long if they simply watch their cancers rather than have them surgically removed, according to the results of a landmark clinical trial that could upend the medical approach to a disease that affects 1 in 6 men. The study, which focused on cancers still confined to the prostate, should reassure patients who want to avoid distressing side effects of surgery - such as urinary incontinence...
May 15, 2007 | From Times Staff and Wire Reports
Dr. John K. Lattimer, 92, a renowned urologist and ballistics expert who was chosen by President Kennedy's family to examine evidence in his assassination, died Thursday at a hospice near his home in Englewood, N.J. A professor and chairman of the urology department at Columbia University's College of Physicians and Surgeons for 25 years, Lattimer was known for helping establish pediatric urology as a discipline and developed a cure for renal tuberculosis.
Los Angeles Times Articles